Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.
<EQUETROTM, mechanism, Acetazolamide>, <EQUETROTM, mechanism, azole antifungals>, <EQUETROTM, mechanism, cimetidine>, <EQUETROTM, mechanism, clarithromycin>, <EQUETROTM, mechanism, dalfopristin>, <EQUETROTM, mechanism, danazol>, <EQUETROTM, mechanism, delavirdine>, <EQUETROTM, mechanism, diltiazem>, <EQUETROTM, mechanism, erythromycin>, <EQUETROTM, mechanism, fluoxetine>, <EQUETROTM, mechanism, fluvoxamine>, <EQUETROTM, mechanism, isoniazid>, <EQUETROTM, mechanism, itraconazole>, <EQUETROTM, mechanism, ketoconazole>, <EQUETROTM, mechanism, loratadine>, <EQUETROTM, mechanism, nefazodone>, <EQUETROTM, mechanism, niacinamide>, <EQUETROTM, mechanism, nicotinamide>, <EQUETROTM, mechanism, protease inhibitors>, <EQUETROTM, mechanism, propoxyphene>, <EQUETROTM, mechanism, quinine>, <EQUETROTM, mechanism, quinupristin>, <EQUETROTM, mechanism, troleandomycin>, <EQUETROTM, mechanism, valproate>, <EQUETROTM, mechanism, verapamil>, <EQUETROTM, mechanism, zileuton>